These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1550866)

  • 1. TNF as immunomodulatory agent.
    Bonavida B
    Immunol Ser; 1992; 56():315-29. PubMed ID: 1550866
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunomodulatory properties of recombinant murine and human tumor necrosis factor.
    Talmadge JE; Phillips H; Schneider M; Rowe T; Pennington R; Bowersox O; Lenz B
    Cancer Res; 1988 Feb; 48(3):544-50. PubMed ID: 3257167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
    Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
    J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
    Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
    Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cellular immunity mediators in viral diseases (a review of the foreign literature)].
    Shepel' NG
    Veterinariia; 1978 Mar; (3):109-13. PubMed ID: 347691
    [No Abstract]   [Full Text] [Related]  

  • 6. Some requirements for the secretion of tumour necrosis factor and its cytotoxic activity in vitro.
    Danielová V; Holubová J; Sourek J
    Folia Biol (Praha); 1991; 37(3-4):179-88. PubMed ID: 1822445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.
    Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ
    J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble and membrane-bound TNF-alpha are involved in the cytotoxic activity of B cells from tumor-bearing mice against tumor targets.
    Lopez-Cepero M; Garcia-Sanz JA; Herbert L; Riley R; Handel ME; Podack ER; Lopez DM
    J Immunol; 1994 Apr; 152(7):3333-41. PubMed ID: 8144919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor necrosis factor (TNF)--its biochemical characteristics and biological properties].
    Skotnicki AB; Rucińska M
    Przegl Lek; 1989; 46(10):736-43. PubMed ID: 2594993
    [No Abstract]   [Full Text] [Related]  

  • 10. Divergent effects of tumor necrosis factor-alpha and lymphotoxin-alpha on lethal endotoxemia and infection with live Salmonella typhimurium in mice.
    Dharmana E; Keuter M; Netea MG; Verschueren IC; Kullberg BJ
    Eur Cytokine Netw; 2002; 13(1):104-9. PubMed ID: 11956028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
    Green LM; Reade JL; Ware CF; Devlin PE; Liang CM; Devlin JJ
    J Immunol; 1986 Dec; 137(11):3488-93. PubMed ID: 2431035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of cellular immunity in multiple sclerosis].
    Caputo D; Zibetti A; Manara F; Bisaccia G
    Minerva Med; 1977 Feb; 68(6):413-6. PubMed ID: 300150
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo.
    Bromberg JS; Chavin KD; Kunkel SL
    J Immunol; 1992 Jun; 148(11):3412-7. PubMed ID: 1588040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly I:C activated macrophages are tumoricidal for TNF-alpha-resistant 3LL tumor cells.
    Remels L; Fransen L; Huygen K; De Baetselier P
    J Immunol; 1990 Jun; 144(11):4477-86. PubMed ID: 2111350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
    Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
    J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity.
    Paya CV; Kenmotsu N; Schoon RA; Leibson PJ
    J Immunol; 1988 Sep; 141(6):1989-95. PubMed ID: 2844893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nonspecific cytolysis and its significance in rheumatism patients].
    Sachkov VI; Samsonov MA; Voĭtko NE; Redziuk LA; Sycheva AN
    Lab Delo; 1979; (1):9-11. PubMed ID: 83448
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in the tumor necrosis factor-alpha-mediated lysis by fixed natural cytotoxic cells and fixed cytotoxic macrophages.
    Vanderslice WE; Collins JL
    J Immunol; 1991 Jan; 146(1):156-61. PubMed ID: 1984442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mediators in cellular immunity (author's transl)].
    Sawada J; Osawa T
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):860-75. PubMed ID: 4612616
    [No Abstract]   [Full Text] [Related]  

  • 20. Independent protective effects for tumor necrosis factor and lymphotoxin alpha in the host response to Listeria monocytogenes infection.
    Roach DR; Briscoe H; Saunders BM; Britton WJ
    Infect Immun; 2005 Aug; 73(8):4787-92. PubMed ID: 16040991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.